LymphedemaV1, Main, Exploration, bibRecord, 005691

Prevalence of upper-body symptoms following breast cancer and its relationship with upper-body function and lymphedema.

Identifieur interne : 005691 ( Main/Exploration ); précédent : 005690; suivant : 005692

Prevalence of upper-body symptoms following breast cancer and its relationship with upper-body function and lymphedema.

Auteurs : S C Hayes [Australie] ; S. Rye ; D. Battistutta ; B. Newman

Source :

Lymphology [ 0024-7766 ] ; 2010.

RBID : pubmed:21446573

Descripteurs français

KwdFr :
- Adulte, Adulte d'âge moyen, Bras (physiopathologie), Femelle, Humains, Lymphadénectomie (effets indésirables), Lymphoedème (épidémiologie), Lymphoedème (étiologie), Métastase lymphatique, Prévalence, Sujet âgé, Tumeurs du sein (), Tumeurs du sein (physiopathologie), Études longitudinales.
MESH :
- effets indésirables : Lymphadénectomie.
- physiopathologie : Bras, Tumeurs du sein.
- épidémiologie : Lymphoedème.
- étiologie : Lymphoedème.
- Adulte, Adulte d'âge moyen, Femelle, Humains, Métastase lymphatique, Prévalence, Sujet âgé, Tumeurs du sein, Études longitudinales.

English descriptors

KwdEn :
- Adult, Aged, Arm (physiopathology), Breast Neoplasms (physiopathology), Breast Neoplasms (surgery), Female, Humans, Longitudinal Studies, Lymph Node Excision (adverse effects), Lymphatic Metastasis, Lymphedema (epidemiology), Lymphedema (etiology), Middle Aged, Prevalence.
MESH :
- adverse effects : Lymph Node Excision.
- epidemiology : Lymphedema.
- etiology : Lymphedema.
- physiopathology : Arm, Breast Neoplasms.
- surgery : Breast Neoplasms.
- Adult, Aged, Female, Humans, Longitudinal Studies, Lymphatic Metastasis, Middle Aged, Prevalence.

Abstract

This investigation describes the prevalence of upper-body symptoms in a population-based sample of women with breast cancer (BC) and examines their relationships with upper-body function (UBF) and lymphedema, as two clinically important sequelae. Australian women (n=287) with unilateral BC were assessed at three-monthly intervals, from six to 18 months post-surgery (PS). Participants reported the presence and intensity of upper-body symptoms on the treated side. Objective and self-reported UBF and lymphedema (bioimpedance spectroscopy) were also assessed. Approximately 50% of women reported at least one moderate-to-extreme symptom at 6- and at 18-months PS. There was a significant relationship between symptoms and function (p < 0.01), whereby perceived and objective function declined with increasing number of symptoms present. Those with lymphedema were more likely to report multiple symptoms, and presence of symptoms at baseline was associated with an increased risk of lymphedema (ORs > 1.3, p = 0.02), although presence of symptoms explained only 5.5% of the variation in the odds for lymphedema. Upper-body symptoms are common and persistent following breast cancer and are associated with clinical ramifications, including reduced UBF and increased risk of developing lymphedema. However, using the presence of symptoms as a diagnostic indicator or prognosticator of lymphedema has its limitations.

PubMed: 21446573

Affiliations:

Australie

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prevalence of upper-body symptoms following breast cancer and its relationship with upper-body function and lymphedema.</title>
<author><name sortKey="Hayes, S C" sort="Hayes, S C" uniqKey="Hayes S" first="S C" last="Hayes">S C Hayes</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Public Health, Faculty of Health, Queensland University of Technology, Queensland, Australia. sc.hayes@qut.edu.au</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Public Health, Faculty of Health, Queensland University of Technology, Queensland</wicri:regionArea>
<wicri:noRegion>Queensland</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Rye, S" sort="Rye, S" uniqKey="Rye S" first="S" last="Rye">S. Rye</name>
</author>
<author><name sortKey="Battistutta, D" sort="Battistutta, D" uniqKey="Battistutta D" first="D" last="Battistutta">D. Battistutta</name>
</author>
<author><name sortKey="Newman, B" sort="Newman, B" uniqKey="Newman B" first="B" last="Newman">B. Newman</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:21446573</idno>
<idno type="pmid">21446573</idno>
<idno type="wicri:Area/PubMed/Corpus">002688</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002688</idno>
<idno type="wicri:Area/PubMed/Curation">002688</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002688</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002688</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002688</idno>
<idno type="wicri:Area/Ncbi/Merge">004236</idno>
<idno type="wicri:Area/Ncbi/Curation">004236</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004236</idno>
<idno type="wicri:doubleKey">0024-7766:2010:Hayes S:prevalence:of:upper</idno>
<idno type="wicri:Area/Main/Merge">005740</idno>
<idno type="wicri:Area/Main/Curation">005691</idno>
<idno type="wicri:Area/Main/Exploration">005691</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Prevalence of upper-body symptoms following breast cancer and its relationship with upper-body function and lymphedema.</title>
<author><name sortKey="Hayes, S C" sort="Hayes, S C" uniqKey="Hayes S" first="S C" last="Hayes">S C Hayes</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Public Health, Faculty of Health, Queensland University of Technology, Queensland, Australia. sc.hayes@qut.edu.au</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Public Health, Faculty of Health, Queensland University of Technology, Queensland</wicri:regionArea>
<wicri:noRegion>Queensland</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Rye, S" sort="Rye, S" uniqKey="Rye S" first="S" last="Rye">S. Rye</name>
</author>
<author><name sortKey="Battistutta, D" sort="Battistutta, D" uniqKey="Battistutta D" first="D" last="Battistutta">D. Battistutta</name>
</author>
<author><name sortKey="Newman, B" sort="Newman, B" uniqKey="Newman B" first="B" last="Newman">B. Newman</name>
</author>
</analytic>
<series><title level="j">Lymphology</title>
<idno type="ISSN">0024-7766</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Arm (physiopathology)</term>
<term>Breast Neoplasms (physiopathology)</term>
<term>Breast Neoplasms (surgery)</term>
<term>Female</term>
<term>Humans</term>
<term>Longitudinal Studies</term>
<term>Lymph Node Excision (adverse effects)</term>
<term>Lymphatic Metastasis</term>
<term>Lymphedema (epidemiology)</term>
<term>Lymphedema (etiology)</term>
<term>Middle Aged</term>
<term>Prevalence</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Bras (physiopathologie)</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphadénectomie (effets indésirables)</term>
<term>Lymphoedème (épidémiologie)</term>
<term>Lymphoedème (étiologie)</term>
<term>Métastase lymphatique</term>
<term>Prévalence</term>
<term>Sujet âgé</term>
<term>Tumeurs du sein ()</term>
<term>Tumeurs du sein (physiopathologie)</term>
<term>Études longitudinales</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lymph Node Excision</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Lymphadénectomie</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Bras</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Arm</term>
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Female</term>
<term>Humans</term>
<term>Longitudinal Studies</term>
<term>Lymphatic Metastasis</term>
<term>Middle Aged</term>
<term>Prevalence</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Femelle</term>
<term>Humains</term>
<term>Métastase lymphatique</term>
<term>Prévalence</term>
<term>Sujet âgé</term>
<term>Tumeurs du sein</term>
<term>Études longitudinales</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">This investigation describes the prevalence of upper-body symptoms in a population-based sample of women with breast cancer (BC) and examines their relationships with upper-body function (UBF) and lymphedema, as two clinically important sequelae. Australian women (n=287) with unilateral BC were assessed at three-monthly intervals, from six to 18 months post-surgery (PS). Participants reported the presence and intensity of upper-body symptoms on the treated side. Objective and self-reported UBF and lymphedema (bioimpedance spectroscopy) were also assessed. Approximately 50% of women reported at least one moderate-to-extreme symptom at 6- and at 18-months PS. There was a significant relationship between symptoms and function (p < 0.01), whereby perceived and objective function declined with increasing number of symptoms present. Those with lymphedema were more likely to report multiple symptoms, and presence of symptoms at baseline was associated with an increased risk of lymphedema (ORs > 1.3, p = 0.02), although presence of symptoms explained only 5.5% of the variation in the odds for lymphedema. Upper-body symptoms are common and persistent following breast cancer and are associated with clinical ramifications, including reduced UBF and increased risk of developing lymphedema. However, using the presence of symptoms as a diagnostic indicator or prognosticator of lymphedema has its limitations.</div>
</front>
</TEI>
<affiliations><list><country><li>Australie</li>
</country>
</list>
<tree><noCountry><name sortKey="Battistutta, D" sort="Battistutta, D" uniqKey="Battistutta D" first="D" last="Battistutta">D. Battistutta</name>
<name sortKey="Newman, B" sort="Newman, B" uniqKey="Newman B" first="B" last="Newman">B. Newman</name>
<name sortKey="Rye, S" sort="Rye, S" uniqKey="Rye S" first="S" last="Rye">S. Rye</name>
</noCountry>
<country name="Australie"><noRegion><name sortKey="Hayes, S C" sort="Hayes, S C" uniqKey="Hayes S" first="S C" last="Hayes">S C Hayes</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005691 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005691 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:21446573
   |texte=   Prevalence of upper-body symptoms following breast cancer and its relationship with upper-body function and lymphedema.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:21446573" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

Serveur d'exploration sur le lymphœdème

Prevalence of upper-body symptoms following breast cancer and its relationship with upper-body function and lymphedema.

Prevalence of upper-body symptoms following breast cancer and its relationship with upper-body function and lymphedema.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.